• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于高效使用腺苷注射液的优化双规格西林瓶系统。

An optimal dual-size vial system for the cost-effective usage of Adenoscan.

作者信息

Hung J C, Mahoney D W, Johnston D L, Gibbons R J

机构信息

Nuclear Medicine, Department of Diagnostic Radiology, Mayo Clinic, Rochester, Minn 55905, USA.

出版信息

J Nucl Cardiol. 1998 Mar-Apr;5(2):161-6. doi: 10.1016/s1071-3581(98)90199-4.

DOI:10.1016/s1071-3581(98)90199-4
PMID:9588668
Abstract

BACKGROUND

Adenoscan (Fujisawa USA, Inc., Deerfield, Ill.) has been initially packaged in a 30 ml glass vial for single use only because it contains no preservative. This restricted usage has generated considerable waste and high cost for the patient. Although the new 20 ml vial of Adenoscan provides some reduction in waste, the savings offered by the 20 ml and 30 ml vial system is still not optimal. The purpose of this study was to investigate an optimal dual-size vial system that would provide limited amounts of waste while maintaining its practicality to satisfy different patient populations.

MATERIALS AND RESULTS

The least waste for each potential combination (n = 344) of two vials was calculated by assuming that patient weights (30 to 200 kg) follow a normal distribution. The 6 ml and 15 ml vial combination had the least expected waste for lighter patient populations, and the 9 ml and 15 ml vial system had the least expected waste for heavier populations. The calculated wastes for 4207 patients (83 +/- 19 kg) undergoing adenosine stress myocardial perfusion studies at the Mayo Clinic were 10.5 +/- 9.3 ml (30 ml vial), 5.1 +/- 2.9 ml (20 ml and 30 ml vial system), 1.6 +/- 1.0 ml (6 ml and 15 ml vial system), and 1.8 +/- 1.2 ml (9 ml and 15 ml vial system).

CONCLUSIONS

In general, both the 6 ml and 15 ml and 9 ml and 15 ml vial systems perform better than either the single 30 ml vial or the 20 ml and 30 ml vial system. Furthermore, the 6 ml and 15 ml vial combination offers the lowest expected waste for the actual patient population that underwent the adenosine stress myocardial perfusion imaging studies at our institution.

摘要

背景

腺苷注射液(美国藤泽公司,伊利诺伊州迪尔菲尔德)最初包装在30毫升玻璃小瓶中,仅供单次使用,因为它不含防腐剂。这种受限的使用方式给患者带来了大量的浪费和高昂的费用。尽管新的20毫升腺苷注射液小瓶减少了一些浪费,但20毫升和30毫升小瓶系统所节省的费用仍不理想。本研究的目的是探索一种最佳的双规格小瓶系统,既能减少浪费,又能保持实用性以满足不同患者群体的需求。

材料与结果

通过假设患者体重(30至200千克)呈正态分布,计算了两种小瓶每种潜在组合(n = 344)的最少浪费量。对于较轻的患者群体,6毫升和15毫升小瓶组合的预期浪费最少;对于较重的患者群体,9毫升和15毫升小瓶系统的预期浪费最少。在梅奥诊所接受腺苷负荷心肌灌注研究的4207名患者(83±19千克)中,使用30毫升小瓶时计算出的浪费量为10.5±9.3毫升,使用20毫升和30毫升小瓶系统时为5.1±2.9毫升,使用6毫升和15毫升小瓶系统时为1.6±1.0毫升,使用9毫升和15毫升小瓶系统时为1.8±1.2毫升。

结论

总体而言,6毫升和15毫升以及9毫升和15毫升小瓶系统的表现均优于单个30毫升小瓶或20毫升和30毫升小瓶系统。此外,对于在我们机构接受腺苷负荷心肌灌注成像研究的实际患者群体,6毫升和15毫升小瓶组合的预期浪费最低。

相似文献

1
An optimal dual-size vial system for the cost-effective usage of Adenoscan.一种用于高效使用腺苷注射液的优化双规格西林瓶系统。
J Nucl Cardiol. 1998 Mar-Apr;5(2):161-6. doi: 10.1016/s1071-3581(98)90199-4.
2
Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in Brazil.硼替佐米的理想小瓶规格:巴西多发性骨髓瘤治疗中减少浪费和降低成本的真实数据。
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S82-4. doi: 10.1016/j.jval.2011.05.013.
3
Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States.美国非小细胞肺癌患者护理中的药物浪费及医疗系统成本
J Med Econ. 2018 Aug;21(8):755-761. doi: 10.1080/13696998.2018.1467918. Epub 2018 May 11.
4
Minimization of preventable drug waste through use of a vial combination calculator tool.通过使用小瓶组合计算器工具来减少可预防的药物浪费。
Am J Health Syst Pharm. 2024 May 24;81(11):e311-e321. doi: 10.1093/ajhp/zxae023.
5
Economic and microbiologic evaluation of single-dose vial extension for hazardous drugs.危险药物单剂量小瓶扩展的经济和微生物学评估。
J Oncol Pract. 2012 Jul;8(4):e45-9. doi: 10.1200/JOP.2011.000488. Epub 2012 Jun 12.
6
Budget impact analysis of insulin therapies and associated delivery systems.胰岛素治疗及其相关输送系统的预算影响分析。
Am J Health Syst Pharm. 2012 Jun 1;69(11):958-65. doi: 10.2146/ajhp110333.
7
Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry.腺苷负荷灌注成像的安全性概况:来自腺苷扫描多中心试验注册研究的结果。
J Am Coll Cardiol. 1994 Feb;23(2):384-9. doi: 10.1016/0735-1097(94)90424-3.
8
Characterization of surface properties of glass vials used as primary packaging material for parenterals.用于注射剂的初级包装材料的玻璃小瓶的表面特性表征。
Eur J Pharm Biopharm. 2018 Apr;125:58-67. doi: 10.1016/j.ejpb.2017.12.018. Epub 2018 Jan 10.
9
Minimization of olaratumab drug waste using real-world data.使用真实世界数据将olaratumab药物浪费降至最低限度。
Am J Health Syst Pharm. 2017 Jun 1;74(11):832-842. doi: 10.2146/ajhp160254. Epub 2017 May 1.
10
Cost-minimization analysis of intravenous adenosine and dipyridamole in thallous chloride TI 201 SPECT myocardial perfusion imaging.
Ann Pharmacother. 1997 Sep;31(9):974-9. doi: 10.1177/106002809703100903.

本文引用的文献

1
Intravenous dipyridamole: body weight considerations and dosage requirements.
Am Heart J. 1989 Mar;117(3):702-4. doi: 10.1016/0002-8703(89)90754-0.
2
The packaging of intravenous Persantine.静脉注射潘生丁的包装。
J Nucl Med. 1991 Oct;32(10):2023-4.
3
Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men.女性与男性在检测冠状动脉疾病的准确性及双嘧达莫铊-201心肌灌注显像副作用方面的比较。
Am J Cardiol. 1992 Jul 15;70(2):168-73. doi: 10.1016/0002-9149(92)91270-e.